Three Days Into Trial, Cordis Hacks At Boston's Claims

Law360, New York (October 11, 2007, 12:00 AM EDT) -- In another bid for damage control in the stent suit Boston Scientific Corp. filed against it five years ago, Johnson & Johnson subsidiary Cordis Corp. has asked for judgment as a matter of law on the suit's claims of willful infringement of three patents.

“Litigants that make willful infringement claims have to prove them by clear and convincing evidence. Boston Scientific has failed to do so,” said Cordis in one of the two motions it filed on Thursday in the U.S. District Court for the Northern...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.